Symbiosis C.M.

Private

IsraelHealthcare & Life Scienceshttps://symbiosis-cm.com/

Last Round

Grant

Oct 29, 2024

Total Funding Raised

$4.1M

Company Overview

Symbiosis C.M. is a medical device company that develops adaptive transcatheter heart valve technology for the treatment of mitral regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

transcatheter heart valvemitral regurgitationTMVRtranscatheter mitral valve replacementminimally invasive surgerycardiovascular medical deviceinterventional cardiologyheart valve replacementmedtechcardiac implantstructural heartclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbiosis C.M. Comps

Public and private peers based on sector, stage, and business model.

Symbiosis C.M. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Symbiosis C.M. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 29, 2024
Grant	May 1, 2024
Seed	Dec 1, 2023
Pre Seed	Jan 1, 2023
Grant	Jul 22, 2022
Angel	Jan 1, 2022

View all Funding Rounds

Symbiosis C.M. Investors

Notable investors and investment history

Symbiosis C.M. investors
Investor	Rounds
Coller Capital	Grant
Israel Innovation Authority	Grant, Angel
The Jon DeHaan Foundation	Grant
Jeremy Coller Foundation	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 25, 2025
Grew 56% QoQ, from 9 to 14 employees.
Oct 29, 2024
$200K grant from The Jon De Haan Foundation.

View all signals

Symbiosis C.M. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Symbiosis C.M. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Symbiosis C.M.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael

Employee Range18

Year Founded2021

Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.